Ligand Pharmaceuticals Liabilities:
77.78M for Dec. 31, 2012Ligand Pharmaceuticals Historical Liabilities Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 77.78M |
| Sept. 30, 2012 | 76.27M |
| June 30, 2012 | 85.35M |
| March 31, 2012 | 91.50M |
| Dec. 31, 2011 | 112.40M |
| Sept. 30, 2011 | 120.10M |
| June 30, 2011 | 122.11M |
| March 31, 2011 | 129.14M |
| Dec. 31, 2010 | 80.41M |
| Sept. 30, 2010 | 122.01M |
| June 30, 2010 | 124.94M |
| March 31, 2010 | 131.48M |
| Dec. 31, 2009 | 138.06M |
| Sept. 30, 2009 | 126.58M |
| June 30, 2009 | 141.44M |
| March 31, 2009 | 154.28M |
| Dec. 31, 2008 | 181.81M |
| Sept. 30, 2008 | 145.24M |
| June 30, 2008 | 141.00M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More
LGND Liabilities Benchmarks
| Companies | |
|---|---|
| AVANIR Pharmaceuticals | 47.77M |
| NovaBay Pharmaceuticals | 5.079M |
| Momenta Pharmaceuticals | 42.64M |
LGND Liabilities Rankings
| Overall |
76th percentile 1815 of 7590 |
| Sector |
39th percentile 397 of 651 in Healthcare |
| Industry |
40th percentile 39 of 65 in Drug Manufacturers - Specialty & Generic |
LGND Liabilities Range, Past 5 Years
| Minimum | 76.27M | Sep 2012 |
| Maximum | 181.81M | Dec 2008 |
| Average | 121.15M |
